FCPA Compliance and Ethics Report-Episode 82, continued fallout from GSK in China

In this episode of the FCPA Compliance and Ethics Report, I review the continued fallout from GSK in China. I discuss the trial of Mr and Mrs Humphreys and what it all means for the compliance practitioner going forward.

Embed Video


Topics:  Chief Compliance Officers, China, Compliance, Ethics, FCPA, GlaxoSmithKline, Pharmaceutical, Popular

Published In: General Business Updates, Finance & Banking Updates, International Trade Updates, Mergers & Acquisitions Updates, Securities Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Thomas Fox | Attorney Advertising

Other Videos by Thomas Fox